
Zopolrestat
CAS No. 110703-94-1
Zopolrestat( CP 73850 | CP73850 | CP-73850 | Zopolrestat | Zopolrestatum )
Catalog No. M28023 CAS No. 110703-94-1
Zopolrestat is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 36 | In Stock |
![]() ![]() |
5MG | 58 | In Stock |
![]() ![]() |
10MG | 84 | In Stock |
![]() ![]() |
25MG | 192 | In Stock |
![]() ![]() |
50MG | 311 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameZopolrestat
-
NoteResearch use only, not for human use.
-
Brief DescriptionZopolrestat is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).
-
DescriptionZopolrestat is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).(In Vitro):Zopolrestat is a potent inhibitor of the enzymatic reduction of glyceraldehyde and glucose.(In Vivo):After the administration of Zopolrestat (2.5 mg/kg-50 mg/kg; p.o), the ED50s in reversing already elevated sorbitol accumulation in rat sciatic nerve, retina, and lens in a chronic test were 1.9, 17.6, and 18.4 mg/kg, respectively.
-
In Vitro——
-
In VivoAnimal Model:Male Sprague-Dawley rats (made diabetic by iv injection of streptozotocin). Dosage:2.5 mg/kg-50 mg/kg Administration:P.o.; once-a-day for 5 days Result:Its ED50s in reversing already elevated sorbitol accumulation in rat sciatic nerve, retina, and lens in a chronic test were 1.9, 17.6, and 18.4 mg/kg, respectively.
-
SynonymsCP 73850 | CP73850 | CP-73850 | Zopolrestat | Zopolrestatum
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
Recptorgastrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110703-94-1
-
Formula Weight419.38
-
Molecular FormulaC19H12F3N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (238.45 mM)
-
SMILESOC(=O)Cc1nn(Cc2nc3cc(ccc3s2)C(F)(F)F)c(=O)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Szabadkai Istvan, et al. Novel Thiazolidinone Derivatives, Pharmaceutical Compositions Containing Them And Process For Preparing Same. WO1991008203A1
molnova catalog



related products
-
Finasteride
Finasteride is an orally active testosterone 5-alpha-reductase inhibitor (Ki= 10 nM).
-
Izonsteride
Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.
-
Ranirestat
Ranirestat (AS-3201) is an orally active and potent aldose reductase (AR) inhibitor with neuroprotective properties that ameliorates peripheral nerve dysfunction in rats with advanced diabetic polyneuropathy.